Previous 10 | Next 10 |
Delta, Kelowna, BC - June 11, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to w...
GB Sciences ( OTCQB:GBLX ) has obtained an exclusive license to formulate, manufacture, and sell cannabis-infused oral thin films through its MME-licensed subsidiaries and affiliates, under US Patent Number 10,265,362 B2 issued April 2019. More news on: GB Sciences, Inc., Healthcare stoc...
GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients Canada NewsWire LAS VEGAS, June 11, 2019 Oral thin films provide a convenient and accurate delivery system with increased bioavailability of cannabi...
GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies GBS Global Biopharma's proprietary neuropathic pain therapies are orally-delivered, time-released nanoparticles containing myrcene and other cannabinoid-base...
LAS VEGAS , May 14, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced it is nearing completion of $700,000 in power and water upgrades at its cultivation facility in Las Vegas, NV , which will more than triple the company's flower production capabilit...
GB Sciences ( OTCQB:GBLX ), a partner in GB Sciences Louisiana, LLC, announce s that all cultivation operations at LSU Agricultural Center are now open. More news on: GB Sciences, Inc., Healthcare stocks news, Read more ...
LAS VEGAS , April 16, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX), a partner in GB Sciences Louisiana, LLC, is announcing that all cultivation operations at LSU Agricultural Center are now open. This will allow a continuous harvest for patients by increasing GB Sciences Loui...
LAS VEGAS , April 2, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announced that Dr. Dominick Monaco , GB Sciences' Director of Medical Formulations, will be a featured speaker at the Las Vegas Cannabis Conference TODAY, April 2 , at 4:40pm . He will be discussing "Science...
LAS VEGAS , March 28, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced results from a new study that shows only three chemical varieties of cannabis were sold in the Nevada dispensaries between January 2016 and June 2017 -- despite nearly 400 different "strain n...
LAS VEGAS , March 26, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced that The LSU Agricultural Center (AgCenter) received confirmation from the Louisiana Department of Agriculture and Forestry (LDAF) that GB Sciences Louisiana is deemed suitable for full-scale o...
News, Short Squeeze, Breakout and More Instantly...
LAS VEGAS, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is developing cannabis-inspired anti-inflammatory therapeutics that address Cytokine Release Syndrome (CRS) caused by viral infect...
LAS VEGAS, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is addressing the growing need for anxiety and depression medications through the development of novel, kava-inspired formulations, which...
LAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, has co-published a study in the journal Food and Chemical Toxicology that demonstrates the potential of selec...